Kymera Therapeutics Inc

KYMRNASDAQ · USD
122.06USD0.00 (+3.74%)
3210

Kymera Therapeutics Inc (KYMR) Implied Volatility Current

KYMR implied volatility is 52%. IV Rank is 14%, placing current premiums in the bottom of their 52-week range.

Read more

Tracking KYMR implied volatility helps you identify when options premiums on Kymera Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Kymera Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when KYMR IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Kymera Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For KYMR, tracking metrics like KYMR IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on KYMR signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, general pustular psoriasis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases and fibrosis; and MDM2 program to treat hematological malignancies and solid tumors.

The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where KYMR implied volatility sits today versus where it has been. Our scanner ranks Kymera Therapeutics Inc implied volatility against its historical range, surfaces extremes in KYMR IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Kymera Therapeutics Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
13.89%IV Rank
Low

IV is compressed vs the past year - options are relatively cheap, favoring buyers.

Implied Volatility (30d)52.38%

IV Rank13.89%

Historical Volatility (30d)36.73%

IV - HV+15.65%

As of September 22, 2026

Trade options with IV on your side

Track KYMR IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial